SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease....
Gespeichert in:
Veröffentlicht in: | Journal of virology 2022-03, Vol.96 (5), p.e0179121-e0179121 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0179121 |
---|---|
container_issue | 5 |
container_start_page | e0179121 |
container_title | Journal of virology |
container_volume | 96 |
creator | Huang, Ying Skarlupka, Amanda L Jang, Hyesun Blas-Machado, Uriel Holladay, Nathan Hogan, R Jeffrey Ross, Ted M |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic.
Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report. |
doi_str_mv | 10.1128/jvi.01791-21 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8906421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2613295177</sourcerecordid><originalsourceid>FETCH-LOGICAL-a418t-cd0548379ef6f0bb642447a58b5499065d83229259a4e9ac246ab886240d6ae53</originalsourceid><addsrcrecordid>eNp1kUFLwzAYQIMobk5vnqVHBTuTNEmTizCKU2EgOB3eQtqmmtElM2kH-uut2xx68PQd8njhex8ApwgOEcL8ar4yQ4hSgWKM9kAfQcFjShHZB30IMY5pwl964CiEOYSIEEYOQS8hImGEp33Ap6PHaZy5WYwjZcvo3lZ1q-2nikbRzPg2RJkzttJFY5wNkbHRWHuvm3AMDipVB32ynQPwPL55yu7iycPtfTaaxIog3sRFCSnhSSp0xSqY54xgQlJFeU6JEJDRkicYC0yFIlqoAhOmcs4ZJrBkStNkAK433mWbL3RZaNt4VculNwvlP6RTRv59seZNvrqV5J2dYNQJzrcC795bHRq5MKHQda2sdm2QmKEEC4rStEMvN2jhXQheV7tvEJTfsWUXW65jy7X5YoOrsMBy7lpvuxL_sWe_19iJfy6RfAHcOYXn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2613295177</pqid></control><display><type>article</type><title>SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Huang, Ying ; Skarlupka, Amanda L ; Jang, Hyesun ; Blas-Machado, Uriel ; Holladay, Nathan ; Hogan, R Jeffrey ; Ross, Ted M</creator><contributor>Parrish, Colin R ; Parrish, Colin R.</contributor><creatorcontrib>Huang, Ying ; Skarlupka, Amanda L ; Jang, Hyesun ; Blas-Machado, Uriel ; Holladay, Nathan ; Hogan, R Jeffrey ; Ross, Ted M ; Parrish, Colin R ; Parrish, Colin R.</creatorcontrib><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic.
Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/jvi.01791-21</identifier><identifier>PMID: 34936487</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Antibodies, Viral - blood ; Coinfection - prevention & control ; COVID-19 - immunology ; COVID-19 - prevention & control ; Female ; Ferrets - immunology ; Immunology ; Influenza A Virus, H1N1 Subtype - genetics ; Influenza A Virus, H1N1 Subtype - immunology ; Influenza A Virus, H3N2 Subtype - genetics ; Influenza A Virus, H3N2 Subtype - immunology ; Influenza Vaccines - immunology ; Orthomyxoviridae Infections - immunology ; Orthomyxoviridae Infections - prevention & control ; Spotlight ; Spotlight Selection ; Vaccination ; Vaccines and Antiviral Agents ; Virus Shedding</subject><ispartof>Journal of virology, 2022-03, Vol.96 (5), p.e0179121-e0179121</ispartof><rights>Copyright © 2022 American Society for Microbiology.</rights><rights>Copyright © 2022 American Society for Microbiology. 2022 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a418t-cd0548379ef6f0bb642447a58b5499065d83229259a4e9ac246ab886240d6ae53</citedby><cites>FETCH-LOGICAL-a418t-cd0548379ef6f0bb642447a58b5499065d83229259a4e9ac246ab886240d6ae53</cites><orcidid>0000-0003-1947-7469</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906421/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906421/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34936487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Parrish, Colin R</contributor><contributor>Parrish, Colin R.</contributor><creatorcontrib>Huang, Ying</creatorcontrib><creatorcontrib>Skarlupka, Amanda L</creatorcontrib><creatorcontrib>Jang, Hyesun</creatorcontrib><creatorcontrib>Blas-Machado, Uriel</creatorcontrib><creatorcontrib>Holladay, Nathan</creatorcontrib><creatorcontrib>Hogan, R Jeffrey</creatorcontrib><creatorcontrib>Ross, Ted M</creatorcontrib><title>SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets</title><title>Journal of virology</title><addtitle>J Virol</addtitle><addtitle>J Virol</addtitle><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic.
Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report.</description><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>Coinfection - prevention & control</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - prevention & control</subject><subject>Female</subject><subject>Ferrets - immunology</subject><subject>Immunology</subject><subject>Influenza A Virus, H1N1 Subtype - genetics</subject><subject>Influenza A Virus, H1N1 Subtype - immunology</subject><subject>Influenza A Virus, H3N2 Subtype - genetics</subject><subject>Influenza A Virus, H3N2 Subtype - immunology</subject><subject>Influenza Vaccines - immunology</subject><subject>Orthomyxoviridae Infections - immunology</subject><subject>Orthomyxoviridae Infections - prevention & control</subject><subject>Spotlight</subject><subject>Spotlight Selection</subject><subject>Vaccination</subject><subject>Vaccines and Antiviral Agents</subject><subject>Virus Shedding</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUFLwzAYQIMobk5vnqVHBTuTNEmTizCKU2EgOB3eQtqmmtElM2kH-uut2xx68PQd8njhex8ApwgOEcL8ar4yQ4hSgWKM9kAfQcFjShHZB30IMY5pwl964CiEOYSIEEYOQS8hImGEp33Ap6PHaZy5WYwjZcvo3lZ1q-2nikbRzPg2RJkzttJFY5wNkbHRWHuvm3AMDipVB32ynQPwPL55yu7iycPtfTaaxIog3sRFCSnhSSp0xSqY54xgQlJFeU6JEJDRkicYC0yFIlqoAhOmcs4ZJrBkStNkAK433mWbL3RZaNt4VculNwvlP6RTRv59seZNvrqV5J2dYNQJzrcC795bHRq5MKHQda2sdm2QmKEEC4rStEMvN2jhXQheV7tvEJTfsWUXW65jy7X5YoOrsMBy7lpvuxL_sWe_19iJfy6RfAHcOYXn</recordid><startdate>20220309</startdate><enddate>20220309</enddate><creator>Huang, Ying</creator><creator>Skarlupka, Amanda L</creator><creator>Jang, Hyesun</creator><creator>Blas-Machado, Uriel</creator><creator>Holladay, Nathan</creator><creator>Hogan, R Jeffrey</creator><creator>Ross, Ted M</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1947-7469</orcidid></search><sort><creationdate>20220309</creationdate><title>SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets</title><author>Huang, Ying ; Skarlupka, Amanda L ; Jang, Hyesun ; Blas-Machado, Uriel ; Holladay, Nathan ; Hogan, R Jeffrey ; Ross, Ted M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a418t-cd0548379ef6f0bb642447a58b5499065d83229259a4e9ac246ab886240d6ae53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>Coinfection - prevention & control</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - prevention & control</topic><topic>Female</topic><topic>Ferrets - immunology</topic><topic>Immunology</topic><topic>Influenza A Virus, H1N1 Subtype - genetics</topic><topic>Influenza A Virus, H1N1 Subtype - immunology</topic><topic>Influenza A Virus, H3N2 Subtype - genetics</topic><topic>Influenza A Virus, H3N2 Subtype - immunology</topic><topic>Influenza Vaccines - immunology</topic><topic>Orthomyxoviridae Infections - immunology</topic><topic>Orthomyxoviridae Infections - prevention & control</topic><topic>Spotlight</topic><topic>Spotlight Selection</topic><topic>Vaccination</topic><topic>Vaccines and Antiviral Agents</topic><topic>Virus Shedding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Ying</creatorcontrib><creatorcontrib>Skarlupka, Amanda L</creatorcontrib><creatorcontrib>Jang, Hyesun</creatorcontrib><creatorcontrib>Blas-Machado, Uriel</creatorcontrib><creatorcontrib>Holladay, Nathan</creatorcontrib><creatorcontrib>Hogan, R Jeffrey</creatorcontrib><creatorcontrib>Ross, Ted M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Ying</au><au>Skarlupka, Amanda L</au><au>Jang, Hyesun</au><au>Blas-Machado, Uriel</au><au>Holladay, Nathan</au><au>Hogan, R Jeffrey</au><au>Ross, Ted M</au><au>Parrish, Colin R</au><au>Parrish, Colin R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets</atitle><jtitle>Journal of virology</jtitle><stitle>J Virol</stitle><addtitle>J Virol</addtitle><date>2022-03-09</date><risdate>2022</risdate><volume>96</volume><issue>5</issue><spage>e0179121</spage><epage>e0179121</epage><pages>e0179121-e0179121</pages><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic.
Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>34936487</pmid><doi>10.1128/jvi.01791-21</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-1947-7469</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-538X |
ispartof | Journal of virology, 2022-03, Vol.96 (5), p.e0179121-e0179121 |
issn | 0022-538X 1098-5514 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8906421 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Animals Antibodies, Viral - blood Coinfection - prevention & control COVID-19 - immunology COVID-19 - prevention & control Female Ferrets - immunology Immunology Influenza A Virus, H1N1 Subtype - genetics Influenza A Virus, H1N1 Subtype - immunology Influenza A Virus, H3N2 Subtype - genetics Influenza A Virus, H3N2 Subtype - immunology Influenza Vaccines - immunology Orthomyxoviridae Infections - immunology Orthomyxoviridae Infections - prevention & control Spotlight Spotlight Selection Vaccination Vaccines and Antiviral Agents Virus Shedding |
title | SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T08%3A37%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SARS-CoV-2%20and%20Influenza%20A%20Virus%20Coinfections%20in%20Ferrets&rft.jtitle=Journal%20of%20virology&rft.au=Huang,%20Ying&rft.date=2022-03-09&rft.volume=96&rft.issue=5&rft.spage=e0179121&rft.epage=e0179121&rft.pages=e0179121-e0179121&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/jvi.01791-21&rft_dat=%3Cproquest_pubme%3E2613295177%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2613295177&rft_id=info:pmid/34936487&rfr_iscdi=true |